Peripheral neuropathy decisions — 2025

The Veteran is granted a total disability rating based on individual unemployability due to service-connected complex partial seizure, right lower extremity neuropathy, and left lower extremity neuropathy associated with Gulf War environmental hazards, as well as a certificate of eligibility for specially adapted housing.

The Board granted service connection for PTSD with memory loss and denied service connection for bilateral hearing loss. The claims for detached retina, left eye, peripheral neuropathy of the upper and lower extremities were remanded.

The Board denied the Veteran's motion to revise an October 2012 rating decision that denied service connection for bilateral lower extremity neuropathy on the basis of clear and unmistakable error (CUE).

The Board denied the veteran's appeal for an earlier effective date than July 27, 2022, for the grant of service connection for right and left lower extremity diabetic neuropathy.

The Board denied increased evaluations for diabetic peripheral neuropathy, diabetes mellitus, type II, and a separate compensable evaluation for dry eye.

The Board granted a total disability rating based on individual unemployability due to the Veteran's service-connected heart and leg disabilities, resolving reasonable doubt in favor of the Veteran.

The Veteran was granted a 100 percent schedular rating for his service-connected sarcomatoid soft-tissue cancer of the bladder, post-operative, effective July 1, 2002. Other claims were denied.

The appeal of the proposed reduction of the rating for diabetes mellitus, type II with bilateral lower extremity neuropathy is dismissed because it was premature and not properly before the Board.

The Board denied increased ratings for diabetic neuropathy and related carpal tunnel syndrome of the left and right upper and lower extremities, finding that the appellant's symptoms were wholly sensory and mild or moderate in severity.

The Board granted service connection for the Veteran's left and right upper extremity neurological impairments, attributing them to exposure to herbicides during his military service.

The Board granted service connection for left lower extremity peroneal mononeuropathy, finding it to be causally related to the Veteran's service-connected left ankle disability.

The Board granted service connection for right and left lower extremity radiculopathy, but denied service connection for peripheral neuropathy. The Veteran was also awarded a 40 percent rating for his radiculopathy.

The Board granted separate 20 percent disability ratings for urinary frequency and 30 percent disability ratings for a neck, left lower extremity neuropathy, and right lower extremity neuropathy. The Board also granted effective dates of September 28, 2022, for the grant of service connection for various conditions.

The Board granted service connection for bilateral plantar fasciitis and remanded the remaining issues for further development.

The Board denied service connection for multiple conditions, including alopecia areata, hidradenitis suppurativa, arthritis, cancer of the larynx, pulmonary embolism, peripheral neuropathy in both upper and lower extremities, renal cell cancer, and sleep apnea, as there was no evidence to support a causal relationship between these conditions and the Veteran's active service.

The Board remands the claims for further development and to correct pre-decisional duty-to-assist errors.

The Board granted service connection for axonal sensorimotor neuropathy in both the left and right lower extremities based on a continuity of symptoms since service.

The Board denied service connection for right upper extremity peripheral neuropathy, left upper extremity peripheral neuropathy, tongue cramps, and skin disorders as the evidence did not support a finding of current disability or nexus to in-service toxic exposures.

The Board granted initial 10 percent ratings for right and left lower extremity deep peroneal neuritis effective December 18, 2024, but denied higher ratings for diabetic peripheral neuropathy and dermatitis.

The veteran was granted increased ratings for migraine headaches, diabetic neuropathy of the right and left lower extremities, as well as additional intermediate-rate SMC increases.